VistaGen preparing for 200-patient Phase 2b study of PH10 in MDD, CEO says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VistaGen preparing for 200-patient Phase 2b study of PH10 in MDD, CEO says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VistaGen Therapeutics" PH10 shows antidepressive benefit in Phase 2a study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VistaGen Therapeutics completes dosing of last patient in Elevate Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Biosciences doses first patient in Phase 1/2 study of MAA-202
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Incyte, MorphoSys announce first patient dosed in Phase 3 frontMIND study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ALX Oncology announces first patient dosed in ASPEN-03 phase 2 study of ALX148
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Biosciences announces first patient dosed in Phase 3 SQ MarzAA study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novan announces final Week-12 visit for last patient in B-SIMPLE4 Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Landos Biopharma doses first patient in Phase 1b study of NX-13
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Trillium Therapeutics doses first patient in Phase 1b study of TT1-622
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Brickell Biotech completes patient enrollment in Phase 3 Cardigan I study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Onconova announces first patient dosed in phase 2 study of Rigosertib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MediWound announces enrollment of first patient in phase 2 study of EscharEx
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MorphoSys, Incyte announce first patient dosed in phase 3 study of Tafasitamab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Chinook Therapeutics doses first patient in Phase 2 AFFINITY basket study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aptinyx recommences patient screening in a Phase 2 study of NYX-458
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
SpringsWorks Therapeutics doses first patient in Phase 1b nirogacestat study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gracell enrolls first patient in Phase 1/2 study of GC007g for B-ALL
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Precigen doses first patient in phase I study of PRGN-201
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Chinook Therapeutics enrolls first patient in Phase 3 ALIGN study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»